Capital Signal

Aroa Biosurgery Limited (ASX: ARX)

Sector: Health Care

Market cap: A$190M (as of 2 Nov 2026)

Designing and selling regenerative healing products

Data as of 2 Nov 2026.

Recent capital raises

DateTypeAmountPriceDiscountSource
24 Aug 2021SPP$47.4M——Filing ↗

Substantial holders — latest moves

DateHolderMoveHoldingSource
19 Oct 2026State Street Australia Ltd ACF Australian Ethical Investment LimitedIncrease6.36% → 7.4%Filing ↗
6 Oct 2026FirstCape Group Limited and its related body corporates, including Harbour Asset Management LimitedDecrease8.82% → 7.755%Filing ↗
7 Aug 2026State Street Australia Ltd ACF Australian Ethical Investment LimitedIncrease5.01% → 6.36%Filing ↗
27 May 2026Acorn Capital LimitedIncrease7.590% → 8.630%Filing ↗
9 Oct 2025Acorn Capital LimitedIncrease6.530% → 7.590%Filing ↗

Director trades — on-market

DateDirectorTradeSource
26 June 2026John Flower DiddamsSold 200,000Filing ↗
6 June 2025John Flower DiddamsSold 160,000Filing ↗
30 Sept 2024Dr. Catherine MohrBought 436,364Filing ↗
16 Feb 2024Philip McCawBought 326,000Filing ↗
30 Aug 2022John Flower DiddamsBought 50,000Filing ↗

Cash and runway

MetricValueAs ofSource
CashA$23M30 Sept 2025Filing ↗

Latest cash figure is from 30 Sept 2025 and may predate a later quarterly filing.

Latest guidance

DatePeriodGuidanceSource
25 Nov 2025FY26We reaffirm our FY26 guidance of NZ$92–100 million in revenue and NZ$5–8 million normalised EBITDA.Filing ↗

Ask about ARX in Claude or ChatGPT

Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:

  • Has ARX raised money in the last year, and at what discount?
  • What was ARX's latest cash position and runway?

Setup guide for Claude, ChatGPT and other MCP clients →

Loading ARX…

Aroa Biosurgery Limited (ASX: ARX): capital raises, holders, director trades | Capital Signal